FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael O'Connell

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Frank A Sinicrope; Greg Yothers; Al Benson; Aimery Degramont; Nathan R Foster; Richard M Goldberg; Roberto Labianca; Michael J O'Connell; Daniel J Sargent; Jean Francois Seitz
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.
Laurence E McCahill; Michael J O'Connell; Nicholas J Petrelli; Saima Sharif; Lawrence D Wagman; Naftali Bechar; Shaker R Dakhil; Louis Fehrenbacher; Jeffrey K Giguere; Lily Lau Lai; Samia H Lopa; Greg Yothers; Norman Wolmark
Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.
Greg Yothers; Jacqueline K Benedetti; A William Blackstock; James J Dignam; Richard M Goldberg; Michael J O'Connell; Leonard B Saltz; Daniel J Sargent; Norman Wolmark
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael O'Connell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Frank A Sinicrope; Greg Yothers; Al Benson; Aimery Degramont; Nathan R Foster; Richard M Goldberg; Roberto Labianca; Michael J O'Connell; Daniel J Sargent; Jean Francois Seitz
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.
Cancer 2013;119(8):1528-36.
2012: Laurence E McCahill; Michael J O'Connell; Nicholas J Petrelli; Saima Sharif; Lawrence D Wagman; Naftali Bechar; Shaker R Dakhil; Louis Fehrenbacher; Jeffrey K Giguere; Lily Lau Lai; Samia H Lopa; Greg Yothers; Norman Wolmark
Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3223-8.
2011: Greg Yothers; Jacqueline K Benedetti; A William Blackstock; James J Dignam; Richard M Goldberg; Michael J O'Connell; Leonard B Saltz; Daniel J Sargent; Norman Wolmark
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Journal of the National Cancer Institute 2011;103(20):1498-506.
2010: Michael J O'Connell; Ian Lavery; Greg Yothers; Soonmyung Paik; Kim M Clark-Langone; Margarita Lopatin; Drew Watson; Frederick L Baehner; Steven Shak; Joffre Baker; J Wayne Cowens; Norman Wolmark
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3937-44.
2010: Beth A Zamboni; Greg Yothers; Mehee Choi; Clifton David Fuller; James J Dignam; Peter C Raich; Charles Thomas; Michael J O'Connell; Norman Wolmark; Samuel Wang
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):2544-8.
2010: Frank A Sinicrope; Nathan R Foster; Daniel J Sargent; Stephen N Thibodeau; Thomas C Smyrk; Michael J O'Connell
Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.
Cancer 2010;116(7):1691-8.
2010: Steven R Alberts; Mark S Roh; Michelle R Mahoney; Michael J O'Connell; David M Nagorney; Lawrence Wagman; Thomas C Smyrk; Timothy L Weiland; Lily Lau Lai; Roderich E Schwarz; Roy Molina; Todor Dentchev; John S Bolton
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):853-8.
2010: Rafaela L Rego; Nathan R Foster; Thomas C Smyrk; M Le; Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Frank A Sinicrope
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
British journal of cancer 2010;102(1):165-72.
2009: Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5124-30.
2009: Carmen J Allegra; Greg Yothers; Michael J O'Connell; Saima Sharif; Linda H Colangelo; Samia H Lopa; Nicholas J Petrelli; Richard M Goldberg; James N Atkins; Thomas E Seay; Louis Fehrenbacher; Seamus O'Reilly; Luis Chu; Catherine A Azar; Norman Wolmark
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3385-90.
2008: Saima Sharif; Michael J O'Connell; Greg Yothers; Samia Lopa; Norman Wolmark
FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.
Cancer investigation 2008;26(9):956-63.
2008: D Lawrence Wickerham; Michael J O'Connell; Joseph P Costantino; Walter M Cronin; Soonmyung Paik; Charles E Geyer; Patricia Anne Ganz; Nicholas Petrelli; Eleftherios P Mamounas; Thomas B Julian; Norman Wolmark
The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.
Seminars in oncology 2008;35(5):522-9.
2008: Frank A Sinicrope; Rafaela L Rego; Kenji Okumura; Nathan R Foster; Michael J O'Connell; Daniel J Sargent; Harold E Windschitl
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5810-8.
2008: Michael J O'Connell; Megan E Campbell; Richard M Goldberg; Axel Grothey; Jean-François Seitz; Jacqueline K Benedetti; Thierry André; Daniel G Haller; Daniel J Sargent
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2336-41.
2007: J Philip Kuebler; Linda H Colangelo; Michael J O'Connell; Roy E Smith; Greg Yothers; Mirsada Begovic; Bridget Robinson; Thomas E Seay; Norman Wolmark
Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
Cancer 2007;110(9):1945-50.
2007: George P Kim; Linda H Colangelo; Soonmyung Paik; Michael J O'Connell; Ilan R Kirsch; Carmen J Allegra; Norman Wolmark
Predictive value of microsatellite instability-high remains controversial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4857; author reply 4857-8.
2007: J Philip Kuebler; H Samuel Wieand; Michael J O'Connell; Roy E Smith; Linda H Colangelo; Greg Yothers; Nicholas J Petrelli; Michael P Findlay; Thomas E Seay; James N Atkins; John L Zapas; J Wendall Goodwin; Louis Fehrenbacher; Ramesh K Ramanathan; BA Conley; Patrick J Flynn; Gamini Soori; Lauren K Colman; Edward A Levine; Keith S Lanier; Norman Wolmark
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2198-204.
2007: Stephanie R Land; Jacek A Kopec; Reena S Cecchini; Patricia Anne Ganz; H Samuel Wieand; Linda H Colangelo; Kate Murphy; J Philip Kuebler; Thomas E Seay; Burton M Needles; James Bearden; Lauren K Colman; Keith S Lanier; Eduardo R Pajon; David Cella; Roy E Smith; Michael J O'Connell; Joseph P Costantino; Norman Wolmark
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2205-11.
2006: James J Dignam; Blase N Polite; Greg Yothers; Peter Raich; Linda H Colangelo; Michael J O'Connell; Norman Wolmark
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
Journal of the National Cancer Institute 2006;98(22):1647-54.
2006: Dulabh K Monga; Michael J O'Connell
Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.
Annals of surgical oncology 2006;13(8):1021-34.
2006: Atilla Soran; Ali Harlak; John W Wilson; Lois Nesbitt; Barry C Lembersky; H Samuel Wienad; Michael J O'Connell
Diverticular disease in patients with colon cancer: subgroup analysis of national surgical adjuvant breast and bowel project protocol C-06.
Clinical colorectal cancer 2006;6(2):140-5.
2006: Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Lois Shepherd; Michelle R Mahoney; James E Krook; Sandra Rayson; Roscoe F Morton; Kendrith M Rowland; John W Kugler
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Clinical colorectal cancer 2006;6(2):133-9.
2006: Barry C Lembersky; H Samuel Wieand; Nicholas J Petrelli; Michael J O'Connell; Linda H Colangelo; Roy E Smith; Thomas E Seay; Jeffrey K Giguere; M Ernest Marshall; Andrew D Jacobs; Lauren K Colman; Atilla Soran; Greg Yothers; Norman Wolmark
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):2059-64.
2005: Michelle R Mahoney; Daniel J Sargent; Michael J O'Connell; Richard M Goldberg; Paul Schaefer; Jan C Buckner
Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9275-81.
2005: Stacy D'Andre; Daniel J Sargent; Stephen S Cha; Thomas R Buroker; John W Kugler; Richard M Goldberg; Michael J O'Connell; Michael A Poon
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.
Clinical colorectal cancer 2005;4(5):325-31.
2004: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Norman Wolmark; Michael J O'Connell; Mirsada Begovic; Cristine Allmer; Linda H Colangelo; Steven R Smalley; Daniel G Haller; James A Martenson; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Christopher G Willett; Richard M Goldberg
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1785-96.
2004: Megan M Garrity; Lawrence J Burgart; Michelle R Mahoney; Harold E Windschitl; Muhammad Salim; Martin Wiesenfeld; James E Krook; John C Michalak; Richard M Goldberg; Michael J O'Connell; Alfred F Furth; Daniel J Sargent; Linda M Murphy; Eunice Hill; Darren L Riehle; Cecelia H Meyers; Thomas E Witzig
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1572-82.
2003: Michael G Haddock; Heidi Nelson; John H Donohue; William E Taylor; Richard M Devine; David M Nagorney; Bruce G Wolff; Michael J O'Connell; Leonard L Gunderson
Intraoperative electron radiotherapy as a component of salvage therapy for patients with colorectal cancer and advanced nodal metastases.
International journal of radiation oncology, biology, physics 2003;56(4):966-73.
2002: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Michelle R Mahoney; James E Krook; Michael J O'Connell
Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4591-6.
2002: Timothy J Hobday; John W Kugler; Michelle R Mahoney; Daniel J Sargent; Jeff A Sloan; Tom R Fitch; James E Krook; Michael J O'Connell; James A Mailliard; Maria Tria Tirona; Loren K Tschetter; Charles D Cobau; Richard M Goldberg
Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4574-80.
2002: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Michael J O'Connell; Cristine Allmer; Steven R Smalley; James A Martenson; Daniel G Haller; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Richard M Goldberg
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
International journal of radiation oncology, biology, physics 2002;54(2):386-96.
2002: Carmen J Allegra; Allyson L Parr; Lester E Wold; Michelle R Mahoney; Daniel J Sargent; Patrick Johnston; Pamela Klein; Katie Behan; Michael J O'Connell; Ralph Levitt; John W Kugler; Maria Tria Tirona; Richard M Goldberg
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1735-43.
2002: Jeff A Sloan; Richard M Goldberg; Daniel J Sargent; Delfino Vargas-Chanes; Suresh Nair; Stephen S Cha; Paul J Novotny; Michael A Poon; Michael J O'Connell; Charles L Loprinzi
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1491-8.
2002: William E Taylor; John H Donohue; Leonard L Gunderson; Heidi Nelson; David M Nagorney; Richard M Devine; Michael G Haddock; Dirk R Larson; Joseph Rubin; Michael J O'Connell
The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer.
Annals of surgical oncology 2002;9(2):177-85.
2002: Jeff A Sloan; Daniel J Sargent; Jed Lindman; Cristine Allmer; Delfino Vargas-Chanes; Edward T. Creagan; James A. Bonner; Michael J O'Connell; Robert J Dalton; Kendrith M Rowland; Burke J Brooks; John A Laurie
A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2002;11(1):37-45.
2001: Luca Stocchi; Heidi Nelson; Daniel J Sargent; Michael J O'Connell; Joel E Tepper; James E Krook; R Beart
Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18):3895-902.
2001: Jeff A Sloan; Charles L Loprinzi; J A Laurine; Paul J Novotny; Delfino Vargas-Chanes; James E Krook; Michael J O'Connell; John W Kugler; Maria Tria Tirona; Carl G Kardinal; Martin Wiesenfeld; Loren K Tschetter; Alan K Hatfield; Paul L Schaefer
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3539-46.
2001: Michael J O'Connell
North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.
Seminars in oncology 2001;28(1 Suppl 1):4-8.
2000: Daniel J Sargent; Richard M Goldberg; Michelle R Mahoney; D W Hillman; T McKeough; S F Hamilton; J M Darcy; V L Anderson; James E Krook; Michael J O'Connell
Rapid reporting and review of an increased incidence of a known adverse event.
Journal of the National Cancer Institute 2000;92(12):1011-3.
1999: James A Martenson; Thomas G Shanahan; Michael J O'Connell; Charles D Cobau; Georgene Schroeder; Patrick A Burch; Ralph Levitt; Kendrith M Rowland
Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.
Cancer 1999;86(4):710-4.
1999: Kevin C Halling; Amy J French; Shannon K McDonnell; Lawrence J Burgart; Daniel J Schaid; Brett J Peterson; L Moon-Tasson; M R Mahoney; Daniel J Sargent; Michael J O'Connell; Thomas E Witzig; Gist Henry Farr; Richard M Goldberg; Stephen N Thibodeau
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
Journal of the National Cancer Institute 1999;91(15):1295-303.
1998: Michael J O'Connell; David M Nagorney; Albert M Bernath; Georgene Schroeder; Robert J Fitzgibbons; James A Mailliard; Patrick A Burch; J S Bolton; Gerardo Colon-Otero; James E Krook
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2528-33.
1998: Stephen N Thibodeau; Amy J French; Julie M Cunningham; David J Tester; Lawrence J Burgart; Patrick C Roche; Shannon K McDonnell; Daniel J Schaid; Cate Walsh Vockley; Virginia V Michels; Gist Henry Farr; Michael J O'Connell
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
Cancer research 1998;58(8):1713-8.
1998: Michael J O'Connell; John A Laurie; M Kahn; Robert J Fitzgibbons; Charles Erlichman; L Shepherd; CG Moertel; W I Kocha; R Pazdur; HS Wieand; Joseph Rubin; Allen M Vukov; John H Donohue; James E Krook; A Figueredo
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):295-300.
1997: Richard M Goldberg; Alan K Hatfield; M Kahn; Daniel J Sargent; James A Knost; Michael J O'Connell; James E Krook; J A Maillard; Martin Wiesenfeld; Paul L Schaefer; Maria Tria Tirona; CG Moertel
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3320-9.
1997: Henry C Pitot; Donald B Wender; Michael J O'Connell; Georgene Schroeder; Richard M Goldberg; Joseph Rubin; James A Mailliard; James A Knost; C Ghosh; RJ Kirschling; Ralph Levitt; Harold E Windschitl
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2910-9.
1997: R Kochhar; Kevin C Halling; S McDonnell; Daniel J Schaid; Amy J French; Michael J O'Connell; D M Nagorney; Stephen N Thibodeau
Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(2):78-84.
1997: Leonard L Gunderson; Heidi Nelson; James A Martenson; S Cha; Michael G Haddock; Richard M Devine; JM Fieck; B Wolff; Roger R Dozois; Michael J O'Connell
Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU.
International journal of radiation oncology, biology, physics 1997;37(3):601-14.
1997: Leonard L Gunderson; Michael G Haddock; Heidi Nelson; S Cha; Richard M Devine; JM Fieck; Bruce G Wolff; Roger R Dozois; Michael J O'Connell
Locally recurrent colorectal cancer: IOERT and EBRT +/-5-FU and maximal resection.
Frontiers of radiation therapy and oncology 1997;31():224-8.
1997: Leonard L Gunderson; Heidi Nelson; James A Martenson; S Cha; Michael G Haddock; Richard M Devine; JM Fieck; Bruce G Wolff; Roger R Dozois; Michael J O'Connell
Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FU.
Frontiers of radiation therapy and oncology 1997;31():204-8.
1997: Michael J O'Connell; James A Mailliard; M J Kahn; J S Macdonald; D G Haller; R J Mayer; HS Wieand
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):246-50.
1996: Leonard L Gunderson; Heidi Nelson; James A Martenson; S Cha; Michael G Haddock; Richard M Devine; J M Fieck; B Wolff; Roger R Dozois; Michael J O'Connell
Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer.
Diseases of the colon and rectum 1996;39(12):1379-95.
1995: M Wiesenfeld; Michael J O'Connell; H S Wieand; N J Gonchoroff; J H Donohue; R J Fitzgibbons; James E Krook; James A Mailliard; JB Gerstner; R Pazdur
Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2324-9.
1994: RF Marschke; H S Wieand; Michael J O'Connell; J Rubin; A J Schutt; Patrick A Burch; J S Kovach
Advanced colorectal adenocarcinoma: treatment with amonafide.
Journal of the National Cancer Institute 1994;86(12):944-5.
1994: S A Cullinan; CG Moertel; H S Wieand; Michael J O'Connell; M A Poon; James E Krook; James A Mailliard; Loren K Tschetter
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):412-6.
1994: T R Buroker; Michael J O'Connell; H S Wieand; James E Krook; JB Gerstner; James A Mailliard; Paul L Schaefer; Ralph Levitt; Carl G Kardinal; Dean H Gesme
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):14-20.
1993: Carl G Kardinal; CG Moertel; H S Wieand; A J Schutt; Michael J O'Connell; K Wright; M Wiesenfeld; Loren K Tschetter; James E Krook
Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma.
Cancer 1993;71(7):2187-90.
1992: Michael J O'Connell; D J Schaid; V Ganju; J Cunningham; J S Kovach; S N Thibodeau
Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?
Cancer 1992;70(6 Suppl):1732-9.
1992: Michael J O'Connell; L L Gunderson
Adjuvant therapy for adenocarcinoma of the rectum.
World journal of surgery 1992;16(3):510-5.
1991: M A Poon; Michael J O'Connell; H S Wieand; James E Krook; JB Gerstner; Loren K Tschetter; Ralph Levitt; Carl G Kardinal; James A Mailliard
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):1967-72.
1991: C G Moertel; L K Kvols; Michael J O'Connell; J Rubin
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
Cancer 1991;68(2):227-32.
1991: James E Krook; Michael J O'Connell; H S Wieand; R W Beart; J E Leigh; John W Kugler; J F Foley; D M Pfeifle; D I Twito
A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer.
Cancer 1991;67(10):2454-8.
1990: Harold E Windschitl; Michael J O'Connell; H S Wieand; James E Krook; Joseph Rubin; CG Moertel; John W Kugler; D M Pfeifle; Richard M Goldberg; J A Laurie
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
Cancer 1990;66(5):853-6.
1990: Matthew M Ames; Ronald L Richardson; J S Kovach; C G Moertel; Michael J O'Connell
Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.
Cancer research 1990;50(1):206-10.
1989: M A Poon; Michael J O'Connell; CG Moertel; H S Wieand; S A Cullinan; L K Everson; James E Krook; James A Mailliard; J A Laurie; Loren K Tschetter
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1407-18.
1989: Michael J O'Connell
A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study.
Cancer 1989;63(6 Suppl):1026-30.
1988: Michael J O'Connell; David Harrington; John D Earle; G J Johnson; J H Glick; R S Neiman; M N Silverstein
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma.
Cancer 1988;61(9):1754-8.
1987: Michael J O'Connell; David Harrington; John D Earle; G J Johnson; J H Glick; P P Carbone; R H Creech; R S Neiman; R B Mann; M N Silverstein
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1329-39.
1987: Michael J O'Connell; D J Klaassen; L K Everson; S Cullinan; H S Wieand
Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
NCI monographs : a publication of the National Cancer Institute 1987;(5):185-8.